Current Portfolio
Agomab Therapeutics
Agomab Therapeutics is a biotechnology company developing therapies that aim to preserve and restore organ function in fibrotic diseases.
Key Facts
- Sector
Life Sciences
- Country
Belgium
- Fund
LSP 7
- Entry
2023
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.